Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP

Written By
Corneli A, Wang M, Agot K, Ahmed K, Lombaard J, Van Damme L, FEM-PrEP study group.

This study was the first to provide empirical evidence on the positive association between perceiving oneself to be at risk of HIV and adherence to pre-exposure prophylaxis (PrEP) within the context of a placebo-controlled PrEP clinical trial. Programmatic implications of the research are that individuals who perceive they are at risk of HIV may be good candidates for taking PrEP to reduce their risk of acquiring HIV.

Back to top